Publication | Closed Access

Cucurbitacin E ameliorates hepatic fibrosis in vivo and in vitro through activation of AMPK and blocking mTOR-dependent signaling pathway

PathologyHepatic FibrosisFatty Liver DiseaseCirrhosisInflammationHepatotoxicityHepatology FibrosisCell SignalingFibrosisLiver PhysiologyHepatology InflammationCucurbitacin EPharmacologyDrug-induced Liver InjuryHepatologyHepatitisLiver DiseaseLiverMedicine